Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can smarter ventilation during lung surgery prevent complications?

NCT ID NCT07772804

Disease control Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 28, 2026 · Updated 3 times

Summary

This trial tests whether a ventilation strategy based on mechanical power—a measure of energy delivered to the lungs—can reduce postoperative pulmonary complications like pneumonia and collapsed lungs in adults undergoing lung resection surgery. Participants are randomly assigned to receive either this mechanical power-based approach or conventional lung-protective ventilation during one-lung ventilation. The study monitors patients for one month after surgery to compare complication rates and other outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mechanical power-based lung protective ventilation
What this could lead to
If effective, this ventilation strategy could reduce serious lung complications after lung surgery, potentially improving recovery and reducing hospital stays.
What could go wrong
This is a single-center trial with 164 participants, so results may not apply broadly. The intervention is complex and may not outperform conventional ventilation in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 164 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * American Society of Anesthesiologists (ASA) physical status I-III * Elective thoracic surgery requiring lung lobectomy under one-lung ventilation * Age 18 years or older * Written informed consent obtained from the patient Exclusion Criteria * Prior history of thoracic surgery * Emergency surgery * Pregnancy or lactation * Known contraindication to one-lung ventilation * Inability to provide informed consent or cooperate with the study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer (diagnosis) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer (diagnosis) Pulmonary complications in surgical patients

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Samsung Medical Center

    Seoul, 06351, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.